Effect of oversulfation on the chemical and biological properties of kappa carrageenan

Carbohydrate Polymers

Volumn 65, Issue 2, 2006, Pages 134-138

  Opoku, Gloria ^a   Qiu, Xiangdong ^a   Doctor, Vasant ^a  

^a PRAIRIE VIEW A AND M UNIVERSITY   (United States)

Author keywords

Coagulation; Kappa carrageenan; Plasminogen; t PA; u PA

Indexed keywords

ABSORPTION; COAGULATION; INORGANIC ACIDS; SULFONATION; TISSUE;

KAPPA CARRAGEENAN; PLASMINOGEN; T-PA; U-PA;

COLLOIDS;

EID: 33746271392     PISSN: 01448617     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.carbpol.2005.12.033     Document Type: Article

References (19)

1. Anderson W., and Duncan J.G. The anticoagulant activity of carrageenan. The Journal of Pharmacy and Pharmacology 17 (1965) 647-654
2. Bayley S.T. X-ray and infrared studies on carrageenan. Biochimica et Biophysica Acta 17 (1955) 194-205
3. Dace R., McBride E., Brooks K., Gander J., Buszko M., and Doctor V.M. Comparison of the anticoagulant action of sulfated and phosphorylated polysaccharides. Thrombosis Research 87 (1997) 113-126
4. Doctor V.M., Lewis D., Coleman M., Kemp M.T., Marbley E., and Sauls V. Anticoagulant properties of semisynthetic polysaccharide sulfates. Thrombosis Research 64 (1991) 413-425
5. Farias W.R.L., Valente A.P., Pereira M.S., and Mourao P.A. Structure and anticoagulant activity of sulfated galactans. Isolation of a unique sulfated galactan from red algae Botryocladia accidentalis and comparison of its anticoagulant action with that of the sulfated galactans from invertebrates. The Journal of Biological Chemistry 275 (2000) 29299-29307
6. Gold H.K., Leinbach R.C., Garabedian H.D., Yasuda T., Johns J.A., Crossbard E.B., et al. Acute coronary reocclusion after thrombolysis with recombinant human tissue-type plasminogen activator. Prevention by a maintenance infusion. Circulation 73 (1986) 347-352
7. Hawkins W.W. Antipeptic and antithrombic properties of carrageenan. The Journal of Laboratory and Clinical Medicine 60 (1962) 641-648
8. Hawkins W.W. Antithrombic activity of carrageenan in human blood. Canadian Journal of Biochemistry and Physiology 41 (1963) 1325-1327
9. Hawkins W.W., and O'Neil A.N. The anticoagulant action in blood of laminarin. Canadian Journal of Biochemistry and Physiology 33 (1955) 545-552
10. Hogg P.J., and Jackson C.M. Fibrin monomer protects thrombin from inactivation by heparin-antithrombin III: Implications for heparin efficacy. Proceedings of the National Academy of Sciences USA 86 (1989) 3619-3623
11. Hogg P.J., and Jackson C.M. Heparin promotes binding of thrombin to fibrin polymer. The Journal of Biological Chemistry 265 (1990) 241-247
12. O'Neal A.N. 3, 6-anhydro-d-galactose as a constituent of k-carrageenan. Journal of the American Chemical Society 77 (1955) 6324-6326
13. Patankar M.S., Ochinger S., Barnett T., Williams R.L., and Clarke G.F. A revised structure for fucoidan may explain some of its biological activities. The Journal of Biological Chemistry 268 (1993) 21770-21776
14. Pereira M.S., Melo F.R., and Mourao P.A.S. Is there a correlation between structure and anticoagulant action of sulfated galactans and sulfated fucans?. Glycobiology 12 (2002) 573-580
15. Pereira M.S., Mulloy B., and Mourao P.A.S. Structure and anticoagulant activity of sulfated fucans: Comparison between the regular, repetitive and linear fucans from echinoderms with the more heterogeneous and branched polymers from brown algae. The Journal of Biological Chemistry 274 (1999) 7656-7667
16. Qiu X., Amarasekara A., and Doctor V.M. Effect of oversulation on the chemical and biological properties of fucoidan. Carbohydrate Polymers 63 (2006) 224-228
17. Thomas, W. (2005). Personal communication. Data published in bulletin by Kelco, C. P. under 'Genu Carrageenan; molecular structure'.
18. Weigl J., and Yaphe W. The enzymatic hydrolysis of carrageenan by Pseudomonas carrageenovara: Purification of kappa-carrageenase. Canadian Journal of Microbiology 12 (1966) 939-947
19. Williams D.O., Borer J., Braunwald E., Chesebro J.H., Cohen L.S., Dalen J., et al. Intravenous recombinant tissue-type plasminogen activator in patients with acute myocardial infarction. Circulation 73 (1986) 338-346